#drug design — Wednesday, July 22, 2026 (2 items)
| 0 | 💬 0 |
Preclinical characterization of a reversible XPO1 inhibitor for cancer therapy.
(nature.com)
|
Nature Communications 2026-07-22 | #cancer #preclinical #apoptosis #drug design #xenograft | |
| 0 | 💬 0 |
Docking of virtual libraries identifies small-molecule agonists of neurotensin receptors with analgesic activity.
(nature.com)
|
Nature Communications 2026-07-22 | #gpcr #analgesia #docking #drug design #ligand-discovery |